EIQ.XA is trading 28.9% up today at A$1.59 following the announcement of senior U.S.-focused leadership appointments aimed at accelerating its American expansion and commercial rollout.
- The company named a new CFO and a senior clinical leader to strengthen its capability to scale U.S. operations.
- Investors are interpreting the strategic hires as a significant step toward monetizing the company's growth strategy and expanding its footprint in the U.S. healthcare market.